Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PDS Biotechnology Q4 EPS $(0.35) Beats $(0.44) Estimate; Cash Balance $56.6M

Author: Benzinga Newsdesk | March 27, 2024 07:38am
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.44) by 20.45 percent. This is a 47.76 percent increase over losses of $(0.67) per share from the same period last year.

Posted In: PDSB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist